96 week results from the MONET trial: a randomized comparison of darunavir/ritonavir with versus without nucleoside analogues, for patients with HIV RNA <50 copies/mL at baseline (Q58000804)
Jump to navigation
Jump to search
article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | 96 week results from the MONET trial: a randomized comparison of darunavir/ritonavir with versus without nucleoside analogues, for patients with HIV RNA <50 copies/mL at baseline |
article |
Statements
96 week results from the MONET trial: a randomized comparison of darunavir/ritonavir with versus without nucleoside analogues, for patients with HIV RNA <50 copies/mL at baseline (English)
Nathan Clumeck
Armin Rieger
Denes Banhegyi
Wolfgang Schmidt
Andrew Hill
Yvonne Van Delft
Christiane Moecklinghoff
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference